• Latest Posts

Roche abandons Wilex to Make Way for Immuno-Oncology

Emmanuelle Charpentier, co-discoverer of CRISPR-Cas9 Technology, comes to Berlin!

A Tale of Love for UniQure and Bristol-Myers Squibb

Roche and Clovis combine drugs to fight lung cancer, the most common cancer worldwide

CRISPR Therapeutics reinforces its Team with Top Executives from Pfizer and McKinsey

18-year-old French Hybrigenics goes to the US with its Acute Myeloid Leukemia Treatment


Pili Printed their First Page with Bacteria-Made Ink!

AstraZeneca’s Oncology Expansion Continues: MedImmune grabs Inovio’s Cancer Vaccine

Oxitec’s revolutionary Genetically Modified Insects acquired by Intrexon for €146M

Evotec enters Immuno-Oncology and Diabetes Therapy with Help from Sanofi

A $500 Million Deal to Reactivate T-cells’ Anti-cancer Response

Fresh Money for a Chlamydia Vaccine Using Synthetic Biology